Whole Person Health and the role of RWE: An interview with Dr Kavita Lamror, Partner, RWE & Digital Transformation, Maxis Clinical Sciences

In a recent interview with Laura Dormer from The Evidence Base, Dr. Kavita Lamror, a seasoned professional in the healthcare industry, shared her insights on Real-World Evidence (RWE), Whole Person Health, and the role of Maxis Clinical Sciences in these areas.

You can view the entire video or view a specific question by entering ‘Fullscreen with Transcript’ or navigate via the ‘Visual Table of Contents’.
This interview and the summary below a comprehensive understanding of the current landscape and future trends in Real-World Evidence and Whole Person Health. Dr. Kavita Lamror’s work at Maxis Clinical Sciences is contributing significantly to these areas, promising a future where healthcare is more integrative, value-driven, person and patient-centric.

Key Takeaways

Dr. Kavita Lamror‘s Background: Dr. Lamror, a clinical doctor with a master’s in public health from Hopkins, has over 16 years of experience in the industry. She has been instrumental in developing value access, analytics, Health Economics and Outcomes Research (HEOR) models, and real-world evidence for products and pharma companies. She has also contributed to the growth of service provider companies through partnerships, mergers, and acquisitions.
Role at Maxis Clinical Sciences: Dr. Lamror joined Maxis Clinical Sciences to spearhead RWE and digital transformation initiatives. She has been leveraging her experience and Maxis’s digital products to manage patient-level data effectively. Her team is also working on generating synthetic datasets and removing bias in these datasets, especially for rare diseases and orphan indications.
Definition of Whole Person Health: Dr. Lamror defines Whole Person Health as an integrative approach towards treating individuals as a whole, rather than focusing on specific body parts or systems. This approach aims to empower individuals to strive for better health and promotes their well-being from a social behavioral perspective.
Role of RWE in Whole Person Health: Real-world evidence plays a crucial role in delivering a vision of Whole Person Health. It helps identify integrative models of care, measure outcomes, and assess the impact of healthcare models on person well-being. It also aids in planning for scalability and implementation at a population level.
Challenges of Utilizing Real-World Data (RWD) in an HEOR/HTA Setting: The challenges include dealing with missing data points, handling data from multiple sources, ensuring scientific integrity, collaborating with data providers, and managing data privacy aspects.
Integration of RWD/E into Clinical Research at Maxis: Maxis works with partners to integrate RWD/E into clinical research. They use a tool that works on clinical data and can be customized according to the client’s needs. They also run Machine Learning algorithms and work towards generating synthetic datasets.
Future of RWE and Whole Person Health: Dr. Lamror hopes that the use of RWE and the mission of Whole Person Health will evolve over the next 5-10 years. She emphasizes the need to identify all stakeholders, ensure data security, exchange data in fair data marts, and move towards technology to reduce dependency on individuals while managing data.

Dr Kavita Lamror
Partner, RWE & Digital Transformation, Maxis Clinical Sciences

Dr Kavita Lamror, a key figure at Maxis Clinical Sciences, spearheads Real-World Evidence and Digital Transformation initiatives. Holding an MPH from Johns Hopkins Bloomberg School of Public Health, her diverse career spans academia, pharma, and medical devices. At Maxis, she leverages her data analytics prowess and evidence-based approach to elevate patient health outcomes. Before her tenure at Maxis, Dr Lamror directed global RWE studies for cardiovascular and central nervous system products at leading pharmaceutical companies. Her visionary leadership has been instrumental in the development of custom RWE products and in transforming Value Evidence functions into revenue-generating verticals.